Literature DB >> 35089237

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum.

.   

Abstract

Entities:  

Year:  2022        PMID： 35089237      PMCID： PMC8797557          DOI： 10.1097/MD.0000000000028714

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
In the article, “Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma”,[ which appears in Volume 98, Issue 2 of Medicine, Figure 1 has been replaced with the below figure.
  1 in total

1.  Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma.

Authors:  Jian-Heng Peng; Xiang Zhang; Jun-Long Song; Liang Ran; Rong Luo; Hong-Yuan Li; Yong-Hong Wang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.